BIOLASE Expects to Report Positive Cash Flow From Operations

BIOLASE Expects to Report Positive Cash Flow From Operations for Q4
BIOLASE Expects to Continue to Generate Positive Cash Flow From
Operations for 2013 Overall 
IRVINE, CA -- (Marketwire) -- 01/22/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
announced today that based on preliminary unaudited financial
results, the Company expects to report that it generated positive
cash flow from operations for Q4 2012.  
"We are pleased with our preliminary unaudited financial results for
Q4 2012. It is rewarding to see that our restructuring efforts over
the past two years have enabled us to turn the Company around and
that we are making significant progress toward achieving our
financial goals," said Federico Pignatelli, Chairman and CEO. "The
trends we are seeing in the adoption of dental lasers also give us
confidence in achieving continued double-digit growth of our core
dental franchise. Based on our current plans, we expect the Company
will continue to generate positive cash flow from operations for the
overall year ending December 31, 2013." 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products that are focused on
technologies that advance the practice of dentistry and medicine. The
Company's laser products incorporate approximately 290 patented and
patent-pending technologies designed to provide biological treatment
and clinically superior performance with less pain and faster
recovery times. Its imaging products provide cutting-edge technology
at competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment and CAD/CAM systems. BIOLASE has sold more than 21,000
Other products under development address ophthalmology and other
medical and consumer markets.  
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at, Facebook at, Twitter at, and
YouTube at  
For further information, please contact: 
Lisa Wilson 
In-Site Communications, Inc. 
Press spacebar to pause and continue. Press esc to stop.